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Background: A recent article in Circulation Research suggests that the protein ABCC6, which when defective is
responsible for pseudoxanthoma elasticum, an inherited condition with skin, eye and cardiovascular manifestations,
is associated with dysfunction in mitochondria – Martin et al.: ABCC6 Localizes to the Mitochondria-Associated
Membrane. Circ Res 2012, 111:516–520. We present complementary information based on a bioinformatics analysis,
which was not performed in the article cited, to examine the suggestion that ABCC6 is localized to mitochondria.
Results: All the computational strategies and integrative approaches that constitute references in the field indicate
that ABCC6 is localized outside of mitochondria.
Conclusion: Our computational and integrative results, including both experimental and predictive data, show that
there is no support in favor of the localization of ABCC6 in mitochondria.
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Pseudoxanthoma elasticum (PXE), an inherited condi-
tion with skin, eye and cardiovascular manifestations
resulting from dystrophic calcification, is caused by a de-
fect in the ATP-binding cassette, subfamily C, member 6
protein (ABCC6) [1]. ABCC6 and the murine ortholog
Abcc6, which have been repeatedly located to the
plasma membrane of the liver and proximal tubule
kidney cells, are virtually absent in affected tissues in
PXE and in related murine conditions [1-3]. These find-
ings are of major pathophysiological significance since
they indicate that ABCC6 mediates remote calcification
via the circulation and that PXE is a systemic condition
[4]. However, a recent article in Circulation Research
claiming that ABCC6 localizes to the mitochondria-
associated membrane (MAM) [5] has given rise to some
debate [6,7]. MAMs have been defined as the contact
sites between mitochondria and the ER with no involve-
ment of any direct membrane fusion [8]. In their article,
the authors describe various structural mitochondrial
changes in Abcc6−/− kidney and heart cells, though not* Correspondence: MaFerre@chu-angers.fr
1CNRS 6214/INSERM 1083, Angers University, Angers, France
2Department of Biochemistry and Genetics, University Hospital, Angers,
France
Full list of author information is available at the end of the article
© 2013 Ferré et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orin liver cells, as well as changes in the endoplasmic
reticulum (ER) bordering mitochondria and decreased
reserve respiration capacity in liver cells. Taken together,
these findings may suggest dysfunction in mitochondria
rather than in MAM. We therefore set out to test the
possibility of ABCC6 being localized to mitochondria,
using the computational and integrative approaches that
are now references in the field.
Computational analysis
Mitochondrial proteins may be targeted to the mito-
chondrial matrix, inner membrane, outer membrane,
or the intermembrane space [9]. Proteins destined for
import into the organelle via a cleavable peptide prese-
quence, typically 15–50 residues long, contain an α-helix
with positively charged residues on one side, and un-
charged hydrophobic residues on the other. Some of
these proteins are subsequently directed to the inner
membrane and the intermembrane space according to
the consecutive peptide sequences they carry.
The identification of the targeting sequence of mito-
chondrial proteins by means of a purely computational
strategy is now well established and commonly used.
Several algorithms have been developed for the detec-
tion of mitochondrial targeting sequences on proteins
translated in the cytosol. Although these tools sufferd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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tions of mitochondrial localization, they all predict the
presence of ABCC6 outside mitochondria and the ER.
Thus:
– Predotar [10] localizes ABCC6 neither in mitochondria
nor the endoplasmic reticulum (p=0.99);
– MitoProt [11] finds a low probability of the protein
being exported to mitochondria (p=0.0304);
– TargetP [12] indicates a location other than
mitochondria and the secretory pathway (score: 0.845);
– PProwler [13] localizes the protein neither in
mitochondria, the secretory pathway, nor the
peroxisomal matrix (score: 0.59);
– CELLO [14], WoLF PSORT [15] and PSORT-II [16]
localize the protein in the plasma membrane; and
– iPSORT [17] predicts the protein has no signaling or
mitochondrial targeting peptide.
In addition, some localization software techniques
[14-16], which rely not only on the N-terminal targeting
sequence but apply to whole-cell localizations, predicts
the localization of ABCC6 in the plasma membrane.
Integrative analysis
Currently, the most successful experimental strategy for
establishing mitochondrial protein localization combines
in-depth protein mass spectrometry of 14 mouse tissue
samples, large-scale green fluorescent protein-tagging mi-
croscopy, machine learning, literature curation, the pres-
ence of mitochondrial-specific protein domains, mRNA
coexpression, targeting-signal prediction, transcriptional in-
duction during mitochondrial proliferation, homology to
yeast mitochondrial proteins, and protein homology to
Rickettsia, a relative of the mitochondrion’s bacterial ances-
tor [18]. The results of all these integrative approaches,
compiled in the online databases MitoP2 [19], MitoCarta
[20], MitoProteome [21], MitoMiner [22], and HMPDb
[23], indicate that ABCC6 is not localized in mitochondria.
The most comprehensive mitochondrial database is
now estimated to be 85 % complete, containing about
1,100 mitochondrial proteins [20]. The incompleteness
may be explained by the fact that the protein compos-
ition of mitochondria varies from one tissue to another.
Approximately half of the mitochondrial proteins are
ubiquitous, whereas the expression of the remainder is
tissue-specific expression [20,24]. However, Martin et al.
[5] found ABCC6 localized to mitochondria in the liver
as well as the kidney, both organs that were studied in
the integrative works cited above.
Conclusions
As emphasized by Martin et al. [5], the determination of
the subcellular location of ABCC6 is critical in decipheringthe exact role of the transporter in physiology, in general,
and in the pathophysiology of PXE, in particular, when
ABCC6 is absent or defective. Biochemical and immuno-
logical approaches have led to the description of ABCC6 as
a cytoplasmic membrane protein. Our computational and
integrative results show that there is no support in favor of
the localization of ABCC6 either in mitochondria or in the
ER membrane.
We hypothesize that the MAM localization of ABCC6
may be transitory. It would be interesting to study the
vesicular traffic through the sites of contact between
mitochondria and the ER, especially as it has been re-
cently shown that the plasma membrane contributes in
part to the lipid bilayers of the autophagosome, creating
a possible pathway requiring the close contact between
ABCC6 and mitochondria during mitophagy [25].
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